Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering Life Science Investing
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments Life Science Investing
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor with twiist Automated Insulin Delivery System Life Science Investing
MiNK Therapeutics and University of Wisconsin-Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy to Evaluate Prevention of Graft-Versus-Host Disease Life Science Investing
Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy Psychedelics Investing
PharmAla To Supply Østfold Hospital Trust with LaNeo MDMA for Clinical Research Life Science Investing
